InnovStone Therapeutics Limited clinical trials

A subsidiary of CSPC Pharmaceutical Group Limited

The registry lists 4 studies whose lead sponsor is InnovStone Therapeutics Limited. 4 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 9, 2026.

Status

Not yet recruiting: 3
Recruiting: 1

Phase

Phase 1: 3
Phase 2: 1

Where

China: 1

Registry sponsor names on this page

InnovStone Therapeutics Limited4 studies

Something wrong with this grouping? Tell us on the CSPC Pharmaceutical Group Limited page.

Studies

Recruiting first, then most recently updated. Showing 4 of 4. All CSPC Pharmaceutical Group Limited studies →

A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and the Effect of Food of SYH2056 in Healthy SubjectsNot yet recruitingNCT07771777Phase 1
Sponsor listed in the registry: InnovStone Therapeutics Limited
A Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2072 TabletsRecruitingNCT07647783Phase 1
Sponsor listed in the registry: InnovStone Therapeutics Limited
A Phase II Study to Evaluate the Efficacy and Safety of SYH2059 Tablets in Adult Patients With Idiopathic Pulmonary FibrosisNot yet recruitingNCT07600021Phase 2
Sponsor listed in the registry: InnovStone Therapeutics Limited
A Single- and Multiple- Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of SYH2059 Powder for InhalationNot yet recruitingNCT07510958Phase 1
Sponsor listed in the registry: InnovStone Therapeutics Limited